1. Background {#sec84124}
=============

Pregnancy is the most sensitive and enjoyable event in a woman's life ([@A11420R1]) that can affect sleep patterns, ability to perform daily living tasks, and quality of life due to systemic changes caused by hormonal, emotional, mental, and physical factors ([@A11420R2]-[@A11420R4]) Changes in sleep patterns during pregnancy might range from 13% to 80% in the first trimester and from 66% to 97% in the third trimester ([@A11420R5]). According to the National Sleep (2007), 79% of the pregnant women experience some form of sleep disorder. More than 72% of pregnant women will experience frequent awakening during night ([@A11420R6]). Changes in sleep patterns leads to daily dysfunction, fatigue, loss of family welfare, increased accidents and as consequently, reduced quality of life ([@A11420R7]). In addition, insomnia-induced reduction in the psychologic relaxation leads to increased anxiety and fear of childcare and accepting maternal role. In this regard, a review of studies on sleep disorders during pregnancy represents an increased risk of preterm birth, low birth weight, and increasing challenges of pregnancy; it is also associated with prolonged labor, using delivery instruments, cesarean, and depression during pregnancy and after delivery. In some cases, it might cause postpartum blues, negative effect on families and indirectly on society, and an economic burden to society ([@A11420R7], [@A11420R8]). According to conducted studies, the poor quality of sleep in the second trimester of pregnancy is directly related to depressive symptoms in late pregnancy ([@A11420R9]). Depression during pregnancy is prevalent as 70% of pregnant women have some symptoms of depression ([@A11420R10], [@A11420R11]). In several studies, 30.6%, 45.7%, and 57% of women had experienced symptoms of depression during pregnancy ([@A11420R12], [@A11420R13]). According to previous studies, the prevalence of depressive symptoms in pregnancy ranges from 8% to 51% ([@A11420R14], [@A11420R15]). Depression is one the most common psychiatric and mood disorders. According to the World Health Organization (WHO), depression is the fourth urgent health problem in the world ([@A11420R16]); moreover, depression after delivery is associated with prenatal depression, The most important risk factor and predictor for depressed mood during post-partum was prenatal depression and 50% of women with depression during pregnancy experienced depression after delivery ([@A11420R17]). Depression leads to complications in the mother and neonate after delivery and is associated with birth of premature, low birth weight infants. Poor health behaviors include substance use (cigarettes, alcohol, and drugs), not seeking prenatal care, and preeclampsia ([@A11420R18], [@A11420R19]). Newborns would experience restlessness, excessive crying, and sleep disturbance during infancy ([@A11420R20]). In the past, it was thought that pregnancy prevent and protect against depression, while studies suggest that not only the depression in the third trimester has high prevalence, but neglecting sleep disorder and considering it as a normal part of pregnancy can affect maternal mental and physical health and might lead to mood disorders.

2. Objectives {#sec84125}
=============

Efforts for reducing maternal mortality and morbidity in pregnancy to extend prenatal care and delivery have led to favorable maternal and childhood health outcomes. Due to the limited research in this area, giving priority to the health of pregnant women by the health services is one of the millennium development goals. Early detection and following mother's depression during pregnancy is important. Thus, the researchers decided to study this field in the hope of being able to increase the protection of women during pregnancy. This could be a step towards the realization of their motto \"Healthy mother and healthy child\".

3. Patients and Methods {#sec84126}
=======================

In this randomized clinical trial, 96 pregnant women with insomnia or poor sleep quality (according to the Pittsburgh Sleep Quality Index \[PSQI\]) who were referred to two health-elected city center shuttle were enrolled after obtaining informed consent. The participants were selected by simple random allocation (the table of random numbers) for receiving prenatal care in Maku City, West Azerbaijan, Iran, from June through November 2012. Inclusion criteria were being Iranian, educated, and gestational age of 16 to 20 weeks according to the first day of the last menstrual period and ultrasound during the first trimester of pregnancy. Those with medical or mental illnesses and drugs, alcohol, sleeping drugs, and hormones use were excluded. Elimination criteria were subjects withdrew from the study, the occurrence of a traumatic event or loss during the study, insignificant change in unpredictable conditions such as sleep, travel, working shifts, and diet, and taking any additional medication during the study. This study was a double-blind study; participants were not informed of the intervention, enrollment, and assigned groups by researcher. Those who administered the interventions and assessed outcomes were blinded to group assignment. Used tools were forms of basic characteristics, PSQI, and Beck\'s Depression Inventory (BDI). Basic characteristic questionnaire included data on age, education, occupation, parity, gestational age, socioeconomic status, body mass index, interval from previous pregnancy, previous delivery, desire for current pregnancy, smoking, fetal sex satisfaction of pregnant woman and his wife, history of fetal malformation in previous pregnancy, and marital status. Sampling was continuous, the first two-part questionnaire included demographic data and PSQI, which were completed by the pregnant women in a quiet room. After review of the questionnaire, women who scored ≥ 5 according to PSQI and ≥ 11 according to BDI were identified as experiencing insomnia or poor quality of sleep. Then the participants were randomly allocated into two groups of 48: control and intervention. The participants with the symptom of severe depression (score \> 35) were referred to a physician. In the intervention group, women were trained on sleep hygiene behaviors education in four groups of 12 through lecture with slides and a provided instructional booklet. The health behavior education was educated in one hour at four sessions with one-week interval, started at week 22 and ended at week 25. Different content at each session include:

The First week: educating about the feature of normal sleep, stages of sleep and duration of stages, total sleep time, and sleep alternation (physical, psychologic, and hormonal) in pregnancy and their causes.

The Second week: providing solution of physical alternation in pregnancy that disturbed sleep and pregnant women' common complications including vomiting, headache, oversleep-fatigue, heartburn, backache, foot spasm, flatulence, constipation, urgency, no daily activity because of fear the losing of pregnancy, and stress.

The third week: arranging a good sleep environment and habits. Participants were taught that room temperature and sounds should be optimized for relaxation ([@A11420R21], [@A11420R22]). A quiet sleep environment was achieved by putting up heavy curtains, maintaining the humidity in the 60% to 70%, selecting comfortable mattresses and bedding, and encouraging participants to lie on their side to enhance feelings of safety and relaxation. Good sleep habits were cultivated, including regular bed/wake-up times, avoiding napping in bed, reducing exposure to light, which causes the release of melatonin and rising body temperature, reducing the time required to fall asleep, and increasing sleep duration, to improve sleep quality. If participants were unable to fall asleep after 30 minutes in bed, they were requested to leave the bedroom and read a book or watch TV until they felt sleepy. Participants were also asked to get up at a regular time, even if they did not have enough sleep the night before ([@A11420R23], [@A11420R24]), reducing emotional stress, which would limits their ability to relax emotionally, affect sleep quality, and alter hormonal balances ([@A11420R25]).

The fourth week: controlling diet, alcohol consumption, and tobacco use. We gave instruction on the proper intake of calcium and magnesium in the daily diet and advised that drinking a glass of warm milk with sugar would help to have a good night's sleep. Avoidance of eating gas-producing food or drinking a large volume of water before going to bed can reduce bloating/decrease urination during the night, both of which affect sleep quality ([@A11420R24], [@A11420R25]). Alcohol should also be avoided before bedtime ([@A11420R23]). Moreover, caffeinated drinks such as tea or coffee should be consumed only in small quantities during the four to six hours before bedtime. Caffeine stimulates the central nervous system, increases heart rate, and excites brain functions, all of which reduce sleepiness ([@A11420R26]) and exercising regularly. We provided information of the beneficial effects of Walking regular on sleep quality and its related factors. Regular exercise encourages the body to release endorphins, which promote sleep, relieve depression, and relax muscles. Exercise in the early evening can promote health, regulate physiologic and psychologic stress, and improve quality of sleep ([@A11420R23], [@A11420R24]). Exercise conducted in the afternoon or two hours before bedtime was would have the greatest positive effect on sleep quality ([@A11420R27]). The control group received no intervention. Only the responsible mid wife for prenatal care was informed of sleep disorders and depression to give up their routine care for them. The sleep quality and depression were checked and there were no differences in that regard two groups (sleep quality: P \< 0.566 and depression: P \< 0.363).

The first and the second follow-up sessions were held to complete BDI at weeks 29 and 33 of pregnancy to evaluate the effect of training. This study Excluded 12 women; six in control group due to no desire to continue study (three women), preterm labor (two women), and migration to other cities (one woman); and six in intervention group due to no desire to continue study (two women), preterm labor (one woman), migration to other cities (two women), and abortion (one woman).

The PSQI is a retrospective self-report questionnaire that measures sleeping patterns and sleep disturbances that existed during the previous month. The PSQI yields a global score ranging from zero to 21, with higher scores indicating worse sleep quality. The PSQI had strong test-retest reliability, and using a cutoff score of five, the measure demonstrated a sensitivity of 89.6% and specificity of 86.5% in distinguishing people with insomnia ([@A11420R28]). The overall reliability coefficient of the Chinese version PSQI was previously estimated at 0.85 ([@A11420R29]). A test-retest reliability (r) of 0.74 over one month was also found for PSQI ([@A11420R30]). The 19 questions of PSQI assess the sleep quality in the seven "component" areas: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. The sum of scores for these seven components yields one global score. Individuals with PSQI scores \< 5 were categorized as good sleepers, and those with scores ≥ 5 were classified as poor sleepers. The PSQI validity and reliability were determined in two studies in Iran. Malekzadegan et al. determined PSQI validity by content validity and reliability via the test-retest method ([@A11420R31]). Hossein Abadi and et al. reported a sensitivity of 90% and a specificity of 87% for PSQI ([@A11420R32]). To determine validity for this study, the PSQI was given to 13 faculty members of Tehran University of Medical Sciences, School of Nursing, and necessary reforms were made. Moreover, we used test-retest to determine the reliability. Briefly, it was given to 15 eligible pregnant women and Cronbach\'s alpha coefficient was calculated after ten days that revealed reliability of 82%. The sixth item of PSQI is devoted to the use of sleep medications in pregnancy while the using sleep medication was an exclusion criteria in this study; hence, this dimension of the instrument was not analyzed considered zero in final score calculation. Depressive symptoms were assessed using the validated and reliable 13-item short-form BDI that highly correlates with the long form ([@A11420R33], [@A11420R34]) The long-form BDI has been validated for use in pregnant women ([@A11420R10]). BDI contains 21 questions, score of each question ranges from zero to three with the total score of the scale ranging from zero to 63. The total scores are interpreted as follows: 1-10, normal; 11-20, mild depression; 21-30, moderate depression; and ≥ 31, severe depression. BDI is a standard questionnaire that its reliability and validity have been verified in several studies in Iran. The data were analyzed using SPSS 16 (SPSS Inc, Chicago, Illinois, the United States). Descriptive statistics including means and standard deviations were calculated for all the variables. Independent-samples t-tests, Chi-square test, Fisher's exact-test, and repeated measure analysis were used to compare the effect of health behavior education on the quality of sleep in study groups. The Ethics Committee of Tehran University of Medical Sciences, Faculty of Nursing and Midwifery, approved the study and all participants gave their informed consent.

4. Results {#sec84127}
==========

The characteristics and sociodemographic data of the 84 participants are summarized in [Tables 1](#tbl21484){ref-type="table"}. Two groups were matched perfectly in basic characteristics. According to [Table 2](#tbl21485){ref-type="table"}, components of sleep quality scores including subjective sleep quality (P \< 0.246), sleep latency (P \< 0.732), sleep duration (P \< 0.474), habitual sleep efficiency (P \< 0.288), sleep disturbances (P \< 0.583), and daytime dysfunction (P \< 0.130) were quite homogeneous between study groups. The comparison of depression measures before intervention and at one month (week 29), and two months (week 33) of intervention in the intervention and control groups are shown in [Tables 3](#tbl21486){ref-type="table"} and [4](#tbl21487){ref-type="table"} [Figure 1](#fig16306){ref-type="fig"}. The depression scores before intervention in the intervention group and control group (P \< 0.363) were perfectly homogeneous. Depression scores at one month (P \< 0.000) and at two month (P \< 0.000) after intervention were significantly different between two groups and the mean of depression score had decreased after interventions.

###### Demographic Status of Pregnant Women Living in Maku Township Who Participated in the Study ^[a](#fn19247){ref-type="table-fn"},\ [b](#fn19248){ref-type="table-fn"},\ [c](#fn19249){ref-type="table-fn"}^

  Groups                                                    Intervention   Control        P Value ^b^
  --------------------------------------------------------- -------------- -------------- -------------
  **Mother age, y**                                         27.26 ± 5.07   27.21 ± 5.80   0.968
  20-25                                                     17 (40.5)      21 (50.1)      
  26-30                                                     14 (33.3)      8 (18)         
  31-35                                                     8 (19)         10 (23.8)      
  36-40                                                     3 (7.1)        3 (7.1)        
  **Mother's education**                                                                  0.404
  Primary                                                   16 (38.1)      19 (45.2)      
  Secondary                                                 13 (31)        9 (21.4)       
  Diploma                                                   9 (21.4)       6 (14.3)       
  Collegiate                                                4 (9.5)        8 (19)         
  **Mother's occupation**                                                                 0.693
  Housekeeper                                               39 (92.9)      35 (83.3)      
  Worker                                                    1 (2.4)        0              
  Employee                                                  1 (2.4)        2 (4.8)        
  Student                                                   1 (2.4)        4 (9.5)        
  Retired                                                   0              0              
  Private                                                   0              1 (2.4)        
  **Economic status**                                                                     
  Good                                                      7 (16.7)       6 (14.3)       0.812
  Moderate                                                  33 (78.6)      33 (78.6)      
  Bad                                                       2 (4.8)        3 (7.1)        
  **Gravida**                                               2.04 ± 0.96    1.90 ± 0.98    0.503
  One                                                       15 (35.7)      18 (42.9)      
  Two                                                       13 (31)        14 (33.3)      
  Three                                                     11 (26.2)      6 (14.3)       
  Four                                                      3 (7.1)        4 (9.5)        
  **Gestational age, wk**                                   18.26 ± 1.76   17.64 ± 1.69   
  15-17                                                     16 (38.1)      23 (59)        0.105
  18-20                                                     26 (61.9)      19 (41)        0.918
  **Body mass index, kg/m** ^**2**^                         24.84 ± 4.70   24.74 ± 4.32   
  15-18.49                                                  3 (7.1)        2 (4.8)        
  18.5-24.99                                                20 (47.6)      20 (47.5)      
  25-29.99                                                  11 (26.2)      13 (31)        
  30-34.99                                                  7 (16.7)       7 (16.7)       
  35-39.99                                                  1 (2.4)        0 (0)          
  **Interval from previous pregnancy, y**                   2.11 ± 1.83    1.8 ± 1.76     0.507
  No Interval                                               15 (35.7)      17 (40.5)      
  1                                                         4 (9.5)        3 (7.1)        
  2                                                         2 (4.8)        4 (9.5)        
  3                                                         3 (7.1)        5 (11.9)       
  ≥ 4                                                       18 (42.9)      3 (31)         
  **Previous delivery**                                                                   0.797
  No Delivery                                               17 (40.5)      18 (42.9)      
  C/S                                                       19 (45.2)      20 (47.6)      
  NVD                                                       6 (14.3)       4 (9.5)        
  **Tendency of pregnancy, Mother**                                                       0.415
  Yes                                                       35 (83.3)      32 (76.2)      
  No                                                        7 (16.7)       10 (23.8)      
  **Tendency of pregnancy, Husband**                                                      0.156
  Yes                                                       40 (95.2)      35 (83.3)      
  No                                                        2 (4.8)        7 (16.7)       
  **Smoking Mother**                                                                      
  Yes                                                       1 (2.4)        1 (2.4)        0.506
  No                                                        41 (97.6)      41 (97.6)      
  **Smoking Husband**                                                                     0.73
  Yes                                                       21 (50)        12 (28.6)      
  No                                                        21 (50)        30 (71.4)      
  **Satisfaction of Fetal Sex, Mother**                                                   
  Yes                                                       32 (78.6)      26 (61.9)      0.095
  No                                                        9 (21.4)       16 (38.1)      
  **Satisfaction of Fetal Sex, Husband**                                                  0.102
  Yes                                                       32 (76.2)      25 (59.5)      
  No                                                        10 (23.8)      17 (40.5)      
  **History of Fetal Malformation in Previous Pregnancy**                                 0.433
  Yes                                                       5 (11.9)       2 (4.8)        
  No                                                        37 (88.2)      40 (95.2)      
  **Marriage Status**                                                                     0.483
  Voluntary                                                 39 (92.9)      38 (85.7)      
  Mandatory                                                 3 (7.1)        6 (14.3)       
  **Total**                                                 42 (100)       42 (100)       

^a^ Data are presented as mean SD or No. (%).

^b^ The P values were tested using the independent-samples t-test, Chi-square, and Fisher's exact-test.

^c^ Abbreviations: C/S: caesarian section; and NVD, normal vaginal delivery.

###### Comparison of Seven Component of Sleep Quality and Previous Intervention in Pregnant Women ^[a](#fn19250){ref-type="table-fn"}^

  Component of Sleep Quality                       Case            Control         P Value^[b](#fn19251){ref-type="table-fn"}^
  ------------------------------------------------ --------------- --------------- ---------------------------------------------
  **Subjective sleep quality (component 1)**                                       
  Very Good                                        1 (2.4)         2 (4.8)         0.246
  Good                                             21 (50)         12 (28.6)       
  Bad                                              10 (23.8)       16 (38)         
  Very Bad                                         10 (23.8)       12 (28.6)       
  **Sleep latency (component 2)**                  2.73 ± 1.62     2.61 ± 1.54     0.732
  0                                                4 (9.5)         3 (7.1)         
  1-2                                              15 (35.7)       15 (35.7)       
  3-4                                              19 (45.2)       21 (50)         
  5-6                                              4 (9.5)         3 (7.1)         
  **Sleep duration (component 3), h**              6.22 ± 1.14     6.40 ± 1.12     0.474
  \> 7                                             16 (38.1)       21 (50)         
  6-7                                              10 (23.8)       11 (26.2)       
  5-6                                              14 (33.3)       7 (16.7)        
  \< 5                                             2 (4.8)         3 (7.1)         
  **Habitual sleep efficiency (component 4), %**   72.58 ± 12.07   75.19 ± 10.30   0.288
  \> 85                                            8 (19)          6 (14.3)        
  75-84                                            11 (26.2)       16 (38.1)       
  65-74                                            11 (26.2)       17 (40.5)       
  \< 65                                            12 (28.6)       3 (7.1)         
  **Sleep disturbances (component 5)**             10.07 ± 3.84    9.64 ± 3.25     0.583
  1-9                                              23 (54.8)       21 (50)         
  10-18                                            19 (45.2)       21 (50)         
  **Use of sleeping medication (component 6)**                                     
  0                                                0               0               \-
  **Daytime dysfunction (component 7)**            3.38 ± 2.15     2.76 ± 1.49     0.130
  0                                                5 (11.9)        2 (4.8)         
  1-2                                              8 (19)          15 (35.7)       
  3-4                                              13 (31)         20 (47.6)       
  5-6                                              16 (38.1)       5 (11.9)        
  **Sleep quality**                                8.80 ± 2.73     8.47 ± 2.58     0.566
  5-10                                             32 (76.2)       33 (78.6)       
  11-21                                            10 (23.8)       9 (21.4)        
                                                                                   
  **Total**                                        42 (100)        42 (100)        \-

^a^ Data are presented as mean ± SD or No. (%).

^b^ The P values were tested using independent-samples t-test or Chi-square test.

###### Comparison of Depression in Evaluated Pregnant Women ^[a](#fn19252){ref-type="table-fn"}^

  Depression             Previous Intervention   One Month After Intervention, Week 29   Two Month After Intervention, Week 33
  ---------------------- ----------------------- --------------------------------------- ---------------------------------------
  **Normal (1-10)**                                                                      
  Intervention           0 (0)                   12 (28.6)                               15 (35.7)
  Control                0 (0)                   8 (19)                                  7 (16.7)
  **Mild (11-20)**                                                                       
  Intervention           23 (54.8)               15 (35.7)                               15 (35.7)
  Control                24 (57.1)               22 (52.4)                               23 (54.7)
  **Moderate (21-30)**                                                                   
  Intervention           10 (23.8)               8 (19)                                  6 (14.3)
  Control                14 (33.3)               9 (21.4)                                9 (21.4)
  **Severe (≥ 31)**                                                                      
  Intervention           9 (21.4)                7 (16.6)                                6 (14.2)
  Control                4 (9.5)                 3 (7.2)                                 3 (7.2)
  **Total**              42 (100)                42 (100)                                42 (100)

^a^ Data are presented as No. (%).

###### Depression Scores Before and at One (F1) and Two Month (F2) of Intervention in Pregnant Women ^[a](#fn19253){ref-type="table-fn"}^

  Depression                                        Case            Control         P Value ^[b](#fn19254){ref-type="table-fn"}^
  ------------------------------------------------- --------------- --------------- ----------------------------------------------
  **Previous intervention**                         22.47 ± 10.08   20.69 ± 7.65    0.363
  **One month after intervention (F1) (29 week)**   14.78 ± 10.14   19.57 ± 8.90    0.000
  **Two month after intervention (F2) (33 week)**   13.33 ± 9.27    18.16 ± 10.20   0.000

^a^ Data are presented as Mean ± SD.

^b^ The P values were tested using the repeated measure A.

![Depression Scores Before and at One (F1) and Two Month (F2) of Intervention in Pregnant Women](ircmj-17-01-11420-i001){#fig16306}

5. Discussion {#sec84128}
=============

We could not find any literature concerning the effect of sleep health behavioral education on the depressed pregnant women with sleep disturbances. Nevertheless, given the frequently reported relationships between sleep disturbances and pregnancy also between sleep disturbances and depression ([@A11420R20]), the findings of this study in the second trimester of pregnancy were not surprising. In addition to sleep quality and depression remained relatively stable during pregnancy. Sleep quality early pregnancy may contribute to the higher development levels of depressive symptoms in later pregnancy, Given that depressive symptoms can lead to clinical depression ([@A11420R35]). When earlier pregnancy physical symptoms and later pregnancy sleep quality were entered in the regression analyses at the same time, earlier pregnancy sleep quality was not a significant predictor of later pregnancy depressive symptomatology as was shown by Skouteris et al. ([@A11420R35]). Moreover, the stability of sleep disturbances across the second and third trimester is consistent with findings on sleep disturbances in pregnant women without depression ([@A11420R36]). Whilst the majority of research has shown that sleep quality is a predictor of depressive symptoms ([@A11420R9], [@A11420R20], [@A11420R35], [@A11420R37]), women who experience greater frequency and severity effect of symptoms on life during earlier stages of pregnancy, also likely experience poorer sleep quality at later pregnancy. This poor sleep quality is associated with depressive symptoms, because of physical symptoms at early to middle second trimester would predict depressive symptoms in the last trimester, both directly and via poor sleep quality (prospectively) ([@A11420R9]). It might be important to screen sleep difficulties during pregnancy and address these difficulties to prevent the development or further increases in depressive symptomatology at a life period when women's wellbeing is particularly important. Indeed, there is evidence from the early postpartum period that women might report symptoms of depression as somatic complaints. This finding also suggests that when fatigue and insomnia are reported by women during the prenatal and postnatal periods, it may be important to check carefully for depressive symptoms as well ([@A11420R35]). Disruptions in sleep appear as early as 11 to 12 weeks of gestation, intensify in the third trimester, and persist into the postpartum period. Studies have found that the experience of sleep problems during pregnancy is associated with an increased risk of depression, both during the pregnancy and in the postpartum period. Clinically, the findings underscore the importance of assessing and monitoring sleep problems throughout the pregnancy and intervening accordingly to alleviate these symptoms and to improve the health-related quality of life of pregnant women. Higher depressed mood score was independently associated with lower health-related quality of life in six of the eight domains, including bodily pain, general health, vitality, social functioning, emotional role, and mental health ([@A11420R37]). Field et al. stated that during both the second and third trimesters of pregnancy, the depressed women had more sleep disturbances and higher depression, anxiety, and anger scores. They also had higher norepinephrine and cortisol levels. The newborns of the depressed mothers also had more sleep disturbances including less time in deep sleep and more time in indeterminate (disorganized) sleep, and they were more active and cried more ([@A11420R20]). The results of these studies were consistent with the recent research findings about relationship between depression on the second trimester pregnancy and sleep quality. The effect of health behavior educations on the depression in pregnant women with sleep disorder might be consistent with results of current research. The present study also confirmed the result of a pilot study on efficacy of sleep hygiene education on sleep quality in working women ([@A11420R38]) that demonstrated significant association between sleep hygiene education and improved participants' sleep quality. Influence of sleep health behavioral education on recovery of depression was consistent with current research. The studies in Iran showed the prevalence of depression in pregnant women as 25%, 28.8%, and 32% ([@A11420R39]-[@A11420R41]). This variation can be due to difference of Sleep quality regarding cultural conditions and appropriate culture conditions predisposing to depression. These results assist to homogenize demographic characteristics of pregnant women to remove the effects of confounding factors on the depression. It could help mothers with adaptation during and after pregnancy, promote maternal mental health by improving their communication skills, draw attention to her needs at this time, identify mothers at risk for depression and sleep disorders by routine prenatal care and counseling programs. Special programs for research and diagnosis of sleep disorders, troubleshooting the cause of the disturbance, and prevention of disorder should be designed to achieve the motto \"Healthy mother and healthy child." Moreover, future researchers may alter the sequence of education courses to confirm overall program effectiveness. We expect that the sleep quality factors that might affect pregnant women with economic difficulties were not addressed by the four-week sleep hygiene education program. Therefore, the association between personal economic issues and sleep quality deserves further examination in the future. Like other studies, this study had some limitations. During answering questions, there might be few mental disorders with little effect to answer questions, which was beyond the control of the researcher. Moreover, undiagnosed disease and the effect of changes in diet and exercise on sleep pattern could have affected the study.

We would like to thank the pregnant women who participated in this research for their assistance and cooperation. We also express our thanks to all the staff in charge of study at Tehran and Urmia University of Medical Science for their cooperation.
